Selective silencing of USP9X in CML cell lines resulted in downregulation of MCL1 and increased sensitivity toward drug and apoptotic stimuli [126]. The gene discussed is USP9X; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.